News Square
Global Crypto News · Real-time Aggregation
📚 Deep Analysis
More →GRVT Burns 1.1 Million Tokens as Countdown to Grvt 2.0 Begins
<strong>[PRESS RELEASE – Singapore, Singapore, October 20th, 2026]</strong> <strong>The discretionary buyback represents close to 1% of circulating supply and precedes four planned product milestones culminating in Grvt 2.0.</strong> <a href="https://grvt.io/" rel="nofollow noopener" target="_blank">>Grvt</a>, a self-custodial trading platform built on its own zero-knowledge (ZK) chain, announced that the Foundation’s token issuer has completed its first GRVT token buyback, purchasing and burning 1.1 million GRVT tokens on the open market. The transaction permanently removed close to 1% of GRVT’s circulating supply at the time of purchase. It marks the first of five milestones ahead of the planned launch of Grvt 2.0 at the end of November 2026. <strong>A Discretionary Buyback with On-Chain Verification</strong> The Foundation’s token issuer intends to conduct further buybacks on a monthly basis. Each transaction remains entirely at the issuer’s discretion, with no predetermined purchase amount or guaranteed schedule. Buybacks are executed through an independent execution partner, with purchased tokens transferred to a designated burn address and permanently removed from circulation. The transactions can be independently verified through the <a href="https://grvt.io/exchange/buybacks" rel="nofollow noopener" target="_blank">>public buyback dashboard</a>, which records the number of tokens purchased and burned, the percentage of circulating supply represented, cumulative burns and on-chain transaction hashes. “The GRVT token is an important part of the ecosystem we are building,” said <strong>Hong, co-founder and CEO of Grvt</strong>. “We welcome the issuer’s buybacks as a demonstration of its long-term commitment to the ecosystem and community. Grvt is expanding its products and markets, and the issuer’s buybacks sit alongside that as a supportive mechanism aimed at reducing circulating token supply.” <strong>Grvt Outlines Four Product Milestones</strong> The announcement follows GRVT’s token generation event in July 2026 and precedes a series of planned launches. <strong>Grvt Earn, scheduled for the End of October,</strong> will introduce yield opportunities backed by tokenized assets, with target yields of up to 11%. Potential returns are expected to derive from underlying asset cash flows, including interest, premiums and invoice-related income. Asset-supplying partners will be announced at launch. Target yields are not guaranteed. <strong>Stable Funding Perps, scheduled for November,</strong> will introduce perpetual futures linked to commodities, stocks, foreign exchange and indices. The contracts are planned to carry zero trading fees and use once-daily funding. Grvt aims to list more than 1,000 markets by the end of December 2026. <strong>Yield as Margin, also scheduled for November,</strong> will allow eligible Grvt Earn balances to support trading positions while continuing to accrue yield, subject to applicable product terms
OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
OpenAI has bought Orchestra Bio, a San Francisco startup whose AI agents help drug companies keep sprawling development programs on schedule, the ChatGPT maker <a href="https://openai.com/index/openai-to-acquire-orchestra-bio/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>announced Tuesday</a>. “Our goal is to help scientists make discoveries and manage the work needed to turn them into treatments that reach patients sooner,” OpenAI said in the announcement. Orchestra’s team and platform will be folded into <a href="https://openai.com/rosalind/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>Rosalind</a>, OpenAI’s family of AI models and tools for biologists and chemists. The financial terms were not disclosed. Getting a new medicine from first idea to U.S. approval takes time—up to 15 years according to OpenAI. Every month shaved off that timeline is a month earlier that a new treatment can reach the people waiting for it, and a month earlier that the company can generate cash. The process is also absurdly expensive: bringing one approved drug to market can cost more than <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12668846/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>$2.6 billion</a>, and <a href="https://arxiv.org/pdf/2106.05386" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">fewer than 10%</a> of candidates that enter human testing ever make it to pharmacy shelves. Beyond the science itself, OpenAI says drug teams have to coordinate work across internal departments and outside partners, often relying on systems that don’t talk to each other. Those partners usually include contract research organizations, the outside labs hired to run studies, and contract manufacturers that produce the experimental drug. Orchestra’s AI agents—software that can watch over tasks and flag problems on its own—work out which activities and deadlines take the hit, gather the relevant information and compare ways to respond, while scientists and program leaders make the final call. Founded in the fall of 2022, Orchestra raised its <a href="https://jobs.8vc.com/companies/orchestra/jobs/28818089-senior-software-engineer" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>seed round</a> from Andreessen Horowitz, Definition Capital, Insight Partners, and 8VC, and about $20 million in total, according to <a href="https://www.caplight.com/company/orchestra-bio" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">Caplight data</a>. The company should not be confused with Orchestra BioMed, an unrelated Nasdaq-listed medical device maker that trades under the ticker OBIO. In April, OpenAI launched <a href="https://decrypt.co/364783/openai-gpt-rosalind-drug-discovery-life-sciences-model" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">GPT-Rosalind</a>, a model built specifically for biology and dru
Yemen's Houthi military spokesman: We did not launch any drones at Medina, Saudi Arabia, on Wednesday.
CoinWorld news, Yemeni Houthi military spokesman: We did not launch any drones at Medina, Saudi Arabia, on Wednesday.
Google Cloud launches Gemini for U.S. government agencies, with access to Oracle ERP and Microsoft Microsoft 365
Google Cloud announced on October 21 the launch of Gemini for government services, aimed at U.S. government agencies. The product was developed jointly by Google Cloud and federal and state government agencies, including the Missouri state government and the U.S. Department of Health and Human Services (HHS). The Gemini product consists of five parts: Skills that teach agents laws, regulations, and operational procedures; connectors that link to existing systems; agents developed by partners; a governance and control platform; and a partner ecosystem. The product supports access to systems such as Oracle ERP and Microsoft 365, allowing government agencies to use relevant information without migrating data. Google said the product meets the highest level of FedRAMP, the U.S. government's cloud service procurement certification program, ensuring that data remains in a private cloud environment within the United States and will not be used to train Google's foundation models without permission.
Russian Deputy Prime Minister Novak: Russia may fully restore diesel exports by the end of the year.
According to CoinWorld news, Russian Deputy Prime Minister Novak stated that Russia may fully resume diesel exports before the end of the year.
标普500期权Put/Call比报1.15
Bjie.com US stock data: The S&P 500 options Put/Call ratio is 1.15, with put option trading volume higher than call option volume for the day. Compared with the same-methodology snapshot 24 hours earlier, it is down 0.04; compared with the same-methodology snapshot 7 days earlier, it is down 0.08.
Nasdaq futures rise on Asia AI boom
CoinWorld news: Nasdaq futures rise after Asia AI boom.
Hongxin Electronics: Net profit for the first three quarters was 217 million yuan, up 139.24% year on year.
According to a CoinWorld report, Hongxin Electronics announced that in the first three quarters of 2026, the company achieved operating revenue of 5.501 billion yuan, a year-on-year decrease of 0.88%, and net profit attributable to shareholders of 217 million yuan, a year-on-year increase of 139.24%. Among this, the third quarter achieved operating revenue of 2.125 billion yuan, a year-on-year increase of 3.36%, and net profit attributable to shareholders of 92.5868 million yuan, a year-on-year increase of 153.51%. During the reporting period, the net profit of the FPC business increased by 830.93% year-on-year, and the net profit of the computing power business increased by 123.13% year-on-year, serving as the company's main sources of profit.
The most recent funding rate for the ETH perpetual contract is 0.006578%.
CoinWorld data: The most recent funding rate for the ETHUSDT perpetual contract is 0.006578%, with longs paying shorts. Compared with the same-metric snapshot 24 hours earlier, it rose by 0.005 percentage points; compared with the same-metric snapshot 7 days earlier, it rose by 0.0049 percentage points.
Israel announces the formation of a space force
CoinWorld news, [Israel announces formation of space force] Cailian Press, October 21 — Israeli Defense Minister Katz said on the 20th that the Israel Defense Forces are forming a space force, a move aimed at making Israel "one of the world's leading countries in the field of space security."